Abstract
The effect of curcumin on liver injury caused by Concanavalin A (Con A) has not been carefully examined. This study was designed to evaluate the protective effect of curcumin on Con A-induced hepatitis in mice. Liver injured mice received curcumin by gavage at a dose of 200 mg/kg body weight before Con A intravenous administration. Curcumin was effective in reducing the elevated plasma levels of aminotransferases and the incidence of liver necrosis compared with Con A-injected control group. Enzyme-linked immunosorbent assay (ELISA) showed that curcumin suppressed proinflammatory cytokines such as tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and interleukin (IL)-4 production in Con A-injected mice. The reduced severity of hepatitis in curcumin pretreated mice correlated with decrease in numbers of liver CD4+ T cells but not CD8+ T cells by immunohistochemical analysis. Furthermore, the expression levels of intercellular adhesion molecule-1 (ICAM-1) and the interferon-inducible chemokine CXCL10 in hepatic tissue were significantly decreased by curcumin pretreatment. In conclusion, curcumin pretreatment protects against T cell-mediated hepatitis in mice.
Similar content being viewed by others
References
Liaw YF, Lee CS, Tsai SL et al (1995) T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 22(5):1368–1373
Ajuebor MN, Carey JA, Swain MG (2006) CCR5 in T cell-mediated liver diseases: what’s going on. J Immunol 177(4):2039–2045
Hong F, Jaruga B, Kim WH et al (2002) Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110(10):1503–1513
Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90(1):196–203
Beldi G, Wu Y, Banz Y et al (2008) Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 48(3):841–852
Tagawa Y, Sekikawa K, Iwakura Y (1997) Suppression of concanavalin A-induced hepatitis in IFN-gamma(−/−) mice, but not in TNF-alpha(−/−) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 159(3):1418–1428
Wolf D, Hallmann R, Sass G et al (2001) TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1—relevance for concanavalin A-induced hepatitis. J Immunol 166(2):1300–1307
Lafdil F, Wang H, Park O et al (2009) Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 137(6):2125–2126
Shetty S, Lalor PF, Adams DH (2008) Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. Toxicology 254(3):136–146
Ajuebor MN, Hogaboam CM, Le T, Proudfoot AE, Swain MG (2004) CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 34(10):2907–2918
Kawasuji A, Hasegawa M, Horikawa M et al (2006) L-selectin and intercellular adhesion molecule-1 regulate the development of concanavalin A-induced liver injury. J Leukoc Biol 79(4):696–705
Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH (2005) CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol 167(3):887–899
Corson TW, Crews CM (2007) Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 130(5):769–774
Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40–59
Tang Y, Zheng S, Chen A (2009) Curcumin eliminates leptin’s effects on hepatic stellate cell activation via interrupting leptin signaling. Endocrinology 150(7):3011–3020
Xie L, Li XK, Funeshima-Fuji N et al (2009) Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 9(5):575–581
Bozza M, Bliss JL, Maylor R et al (1999) Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 30(6):1441–1447
Bonder CS, Norman MU, Swain MG et al (2005) Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 23(2):153–163
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
Siddiqui AM, Cui X, Wu R et al (2006) The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 34(7):1874–1882
Fu Y, Zheng S, Lin J, Ryerse J, Chen A (2008) Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 73(2):399–409
Oo YH, Adams DH (2010) The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 34(1):45–54
Kaneko Y, Harada M, Kawano T et al (2000) Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191(1):105–114
Mizuhara H, O’Neill E, Seki N et al (1994) T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179(5):1529–1537
Sugimoto K, Hanai H, Tozawa K et al (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123(6):1912–1922
Park S, Murray D, John B, Crispe IN (2002) Biology and significance of T-cell apoptosis in the liver. Immunol Cell Biol 80(1):74–83
Scoazec JY, Feldmann G (1994) The cell adhesion molecules of hepatic sinusoidal endothelial cells. J Hepatol 20(2):296–300
Jaruga B, Hong F, Kim WH, Gao B (2004) IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 287(5):G1044–G1052
Li X, Klintman D, Liu Q, Sato T, Jeppsson B, Thorlacius H (2004) Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol 75(3):443–452
Simpson KJ, Henderson NC, Bone-Larson CL, Lukacs NW, Hogaboam CM, Kunkel SL (2003) Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin Sci 104(1):47–63
Zeremski M, Petrovic LM, Chiriboga L et al (2008) Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48(5):1440–1450
Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM (2001) Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167(1):399–406
Author information
Authors and Affiliations
Corresponding author
Additional information
Chuan-tao Tu and Bing Han contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tu, Ct., Han, B., Liu, Hc. et al. Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression. Mol Cell Biochem 358, 53–60 (2011). https://doi.org/10.1007/s11010-011-0920-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-0920-4